Other Considerations: GLP-1 medications may also cause fatigue, headache, dizziness, or changes in taste for some individuals
Schwartz for their contribution to the peer review of this work
Bring a symptom diary to your appointment, documenting headache frequency, severity (rated 010), duration, associated symptoms, and any relieving or aggravating factors
Clinical-stage obesity-related drugs targeting GLP-1R, GIPR, or GDF-8 through November 2024
The injectable pen comes in the same dose strengths available in the United States: 0.25 mg, 0.5 mg, 1 mg, and 2 mg
When the body enters a state of reduced appetite and normalized blood sugar, thermogenesis (heat production) naturally decreases because fewer calories are being consumed and stored